CINCINNATI, Aug. 31 /PRNewswire-FirstCall/ — Kendle (Nasdaq:
KNDL), a leading, global full-service clinical research
organization, today appointed Mark J. Roseman, D.Sc., as the
Company’s new Senior Vice President and Chief Marketing Officer
(CMO), effective immediately. Dr. Roseman brings to Kendle more
than 20 years of senior operations leadership and strategic account
development experience in the clinical services industry and will
have executive-level responsibility for the Company’s worldwide
sales and strategic partnership development efforts. He will report
directly to Chairman and CEO Candace Kendle, PharmD, and will serve
on the Company’s Executive Committee. Dr. Roseman assumes the
Senior Vice President and CMO role from Simon Higginbotham who will
transition to an external consulting role providing strategic
marketing and business development support services for the
Company.
“Mark brings to Kendle a wealth of operational experience and
proven sales success in the CRO industry,” said Dr. Kendle. “We
look forward to his leadership as we drive continued growth in
sales and strengthen Kendle’s position as a multinational top-tier
CRO and strategic partner of choice for our customers.”
Dr. Roseman joins Kendle from i3 Research where he was Vice
President, Business Operations. His experience includes nearly 13
years with PPD, Inc., where he served most recently as Vice
President, Account Management, with responsibility for key customer
accounts. Previously, Dr. Roseman was Vice President, Clinical
Operations, for PPD responsible for all clinical operations
activities in the Wilmington, N.C., and Research Triangle Park
offices with oversight of more than 1,100 employees. In this role
he provided leadership for the centralized study start-up group as
well as the oncology, cardiovascular, anti-viral/anti-infectives,
respiratory, ophthalmology, critical care and ge
‘/>”/>
